Vogt et al. showed that changing the route of vaccine administration of a quadrivalent inactivated influenza vaccine from intramuscular (i.m.)to transcutaneous induces the expansion of vaccine component-reactive CD8+ T cells. The gene discussed is CD8A; the disease is influenza.